Obstetrics & Gynecology Doctors in Johnston, RI Accepting Medicare

2 Obstetrics & Gynecology doctors found. Showing 1 - 2

Maria M O'toole, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1524 Atwood Ave, Suite Ll6, Johnston, RI 02919 Phone: 401-751-3330    Fax: 401-274-1253

Anthony Manocchio, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1524 Atwood Ave, Johnston, RI 02919 Phone: 401-273-1666

News Archive

Global Sources launches new e-magazines to enhance sourcing, marketing services in three fast-growing sectors

Global Sources has launched new verticals for Solar & Energy Saving Products, Medical Products & Supplies and In-Car Electronics & GPS to enhance sourcing and marketing services for buyers and exporters in these high growth sectors.

Nonin Medical to launch, demonstrate NoninConnect pulse oximeter at CES 2014

Nonin Medical, Inc., the inventor of finger pulse oximetry and a leader in noninvasive medical monitoring, today announced it will launch and demonstrate its NoninConnect direct-to-consumer Bluetooth Smart wireless finger pulse oximeter at the International Consumer Electronics Show, Jan. 7-10, at the Las Vegas Convention Center, South Hall 2, Booth #25319.

Ember Therapeutics, Mariel Therapeutics sign definitive merger agreement

Ember Therapeutics, Inc., a Boston-based biotechnology company dedicated to the discovery and development of novel obesity and diabetic related therapies, and Mariel Therapeutics, a privately held, New York-based biotechnology company developing targeted therapies for osteoarthritis and kidney fibrosis using Bone Morphogenetic Protein (BMP)-7, jointly announce today that they have entered into a definitive agreement to merge the two companies.

State highlights: Cuccinelli blasts health law, Sebelius in bid to gain ground in Va. governor's race; N.Y. residents split over law; medi-cal cuts threaten access

A selection of health policy stories from Virginia, New York, California, Oregon, Michigan, Texas and Georgia.

Alnylam Pharmaceuticals publishes encouraging results from Phase II GEMINI study in PNAS

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has published results from its Phase II GEMINI study in the Proceedings of the National Academy of Sciences (PNAS). These data, previously presented at the International Symposium on Respiratory Viral Infections in Singapore in 2008, showed human proof of concept with an RNAi therapeutic in a randomized, double blind, placebo-controlled study.

Read more Medical News

› Verified 7 days ago